|
|
||||||||
School of Public Health, Emory University, Atlanta, GA 30329, USA.
To identify risk factors for uterine fibroids, a case-control design used to analyze data from control subjects enrolled in the Cancer and Steroid Hormone Study. Case patients were 201 women who reported a history of uterine fibroids, and control subjects were 1503 women without fibroids, individually matched by age to case patients. Reporting of fibroids was more frequent among premenopausal women, women who had frequent Papanicolaou (Pap) smears, women who used oral contraceptives and had infrequent Pap smears, and women with higher education. Reporting of fibroids was less frequent among women with a lower body mass index who were current or long-time smokers.
This article has been cited by other articles:
![]() |
E. Somigliana, P. Vercellini, R. Daguati, R. Pasin, O. De Giorgi, and P.G. Crosignani Fibroids and female reproduction: a critical analysis of the evidence Hum. Reprod. Update, September 1, 2007; 13(5): 465 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Eskenazi, M. Warner, S. Samuels, J. Young, P. M. Gerthoux, L. Needham, D. Patterson, D. Olive, N. Gavoni, P. Vercellini, et al. Serum Dioxin Concentrations and Risk of Uterine Leiomyoma in the Seveso Women's Health Study Am. J. Epidemiol., July 1, 2007; 166(1): 79 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Boynton-Jarrett, J. Rich-Edwards, S. Malspeis, S. A. Missmer, and R. Wright A Prospective Study of Hypertension and Risk of Uterine Leiomyomata Am. J. Epidemiol., April 1, 2005; 161(7): 628 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.L. Marino, B. Eskenazi, M. Warner, S. Samuels, P. Vercellini, N. Gavoni, and D. Olive Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study Hum. Reprod., October 1, 2004; 19(10): 2350 - 2355. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S.Y. Sit, F. Modugno, L. M. Hill, J. Martin, and J. L. Weissfeld Transvaginal Ultrasound Measurement of Endometrial Thickness as a Biomarker for Estrogen Exposure Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1459 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Wise, J. R. Palmer, B. L. Harlow, D. Spiegelman, E. A. Stewart, L. L. Adams-Campbell, and L. Rosenberg Reproductive Factors, Hormonal Contraception, and Risk of Uterine Leiomyomata in African-American Women: A Prospective Study Am. J. Epidemiol., January 15, 2004; 159(2): 113 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Baird Invited Commentary: Uterine Leiomyomata--We Know So Little but Could Learn So Much Am. J. Epidemiol., January 15, 2004; 159(2): 124 - 126. [Full Text] [PDF] |
||||
![]() |
D. B. Petitti Combination Estrogen-Progestin Oral Contraceptives N. Engl. J. Med., October 9, 2003; 349(15): 1443 - 1450. [Full Text] [PDF] |
||||
![]() |
E. A. Stewart, A. V. Faur, L. A. Wise, R. J. Reilly, and B. L. Harlow Predictors of Subsequent Surgery for Uterine Leiomyomata After Abdominal Myomectomy Obstet. Gynecol., March 1, 2002; 99(3): 426 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Faerstein, M. Szklo, and N. Rosenshein Risk Factors for Uterine Leiomyoma: A Practice-based Case-Control Study. I. African-American Heritage, Reproductive History, Body Size, and Smoking Am. J. Epidemiol., January 1, 2001; 153(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Faerstein, M. Szklo, and N. B. Rosenshein Risk Factors for Uterine Leiomyoma: A Practice-based Case-Control Study. II. Atherogenic Risk Factors and Potential Sources of Uterine Irritation Am. J. Epidemiol., January 1, 2001; 153(1): 11 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-R. Chen, G. M. Buck, N. G. Courey, K. M. Perez, and J. Wactawski-Wende Risk Factors for Uterine Fibroids among Women Undergoing Tubal Sterilization Am. J. Epidemiol., January 1, 2001; 153(1): 20 - 26. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |